Germany · Delayed Price · Currency is EUR Aumann AG Earnings Call Transcripts
Fiscal Year 2025
-
Revenue dropped 35% to EUR 204 million in 2025, but EBITDA margin improved to 13.8% amid strong cost discipline. Next Automation order intake surged 54%, offsetting E-Mobility weakness, and a dividend of EUR 0.25 per share was proposed.
-
Revenue and order intake declined sharply year-over-year due to weak automotive investment, but profitability remained strong with an 11.6% EBITDA margin. Next automation order intake rose 35%, and the company maintains a robust net cash position and strategic focus on growth beyond automotive.
-
H1 2025 saw revenue drop 23% year-over-year to EUR 108 million, but profitability remained strong with a 10.5% EBITDA margin. Order intake and backlog declined, yet the company maintains guidance for an 8%-10% EBITDA margin in 2025 and is expanding its automation segment beyond automotive.
-
Q1 2025 saw revenue decline 6.2% year-over-year to EUR 60.5 million, but profitability remained strong with a 10.9% EBITDA margin. E-mobility revenue grew 5%, while next automation fell 40%. 2025 revenue is expected to decline, but margins are guided at 8–10%.
Fiscal Year 2024
-
Record revenue and EBITDA growth in 2024 driven by E-mobility, but order intake and backlog declined sharply due to market headwinds. 2025 revenue is expected to fall, though profitability remains strong, with early signs of industry recovery and strategic expansion into new sectors.
-
Revenue and EBITDA grew strongly in the first nine months of 2024, driven by E-mobility, but order intake and backlog declined due to weak automotive demand. The renamed Next Automation segment targets growth beyond automotive, and management expects continued profitability despite a likely revenue dip in 2025.
-
Revenue grew 19% and EBITDA nearly doubled in H1 2024, with strong margins and a robust order backlog supporting full-year guidance. Order intake declined due to weak EV demand, but no cancellations occurred, and M&A remains a strategic focus.